1. Market Research
  2. > Cancer Industry

Leukemia Industry, February 2017 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Diagnostics, Cancer, Therapy, Hematology Instrument, Infectious Disease, Pap Smear, Blood Disease, Blood Supply, Cancer Diagnostic, Transplantation, Cell Therapy, Analgesic, Anti-Infective, Banking, Biopharmaceutical, Biopsy, Cancer Immunotherapy, Cloud Computing, DNA.


 
1-10 of about 300 reports for Leukemia

Purchase Reports From Reputable Market Research Publishers

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2017

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2017

  • $ 2995
  • Industry report
  • February 2017
  • by Currentpartnering

Summary Essential Benchmark Data for Dealmakers - The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2017 report is your one-stop source for providing real-deal information on hundreds ...

Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2017

Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • February 2017
  • by Currentpartnering

Summary Provides understanding and access to the acute and chronic myelogenous leukemia partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Acute ...

Global Leukemia Partnering 2010 to 2017

Global Leukemia Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • February 2017
  • by Currentpartnering

Summary Provides understanding and access to the leukemia partnering deals and agreements entered into by the worlds leading healthcare companies . Description The Global Leukemia Partnering Terms and ...

Acute Myeloid Leukemia (AML) - Epidemiology Forecast To 2023

Acute Myeloid Leukemia (AML) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Acute Myeloid Leukemia (AML) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Acute Myeloid Leukemia (AML) in seven major markets (US, France, Germany, ...

Chronic Lymphocytic Leukemia (CLL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Chronic Lymphocytic Leukemia (CLL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Chronic Lymphocytic Leukemia (CLL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023

Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-API Insights, 2017

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-API Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuste ...

 Chronic Lymphocytic Leukemia (CLL)-API Insights, 2017

Chronic Lymphocytic Leukemia (CLL)-API Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuste ...

 Mast Cell Leukemia-Pipeline Insights, 2017

Mast Cell Leukemia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Mast Cell Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Mast Cell Leukemia. The Delve ...

 Acute Promyelocytic Leukemia-Pipeline Insights, 2017

Acute Promyelocytic Leukemia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Acute Promyelocytic Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Acute Promyelocytic ...

About 5500 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Cytogenetic and Chromosome Industry in Sweden and the US

  • January 2015
    57 pages
  • Cytogenetic  

    Chromosome  

    Leukemia  

  • Sweden  

    United States  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.